Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Collagen type XIV alpha 1 chain (COL14A1) is a structural protein encoded by the COL14A1 gene and belongs to the FACIT (fibril-associated collagens with interrupted triple helices) collagen family[1][4][2]. It plays a key regulatory role in the assembly, organization, and biomechanics of the extracellular matrix by binding to collagen fibrils and supporting proper fibril formation and tissue strength, especially in connective tissues such as tendons, skin, cornea, and lung[1][7][4]. COL14A1 interacts with other matrix molecules and is involved in cell adhesion, regulating cell proliferation and differentiation in various tissues. Altered expression or mutations in this gene have been implicated in fibrotic diseases, some cutaneous disorders, and potentially serve as biomarkers in specific cancer classifications and fibrotic conditions[1][4][7]. COL14A1 is not presently considered a classical therapeutic target such as a receptor, enzyme, or transporter; instead, it functions primarily as an extracellular matrix structural regulator[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen type XIV alpha 1 chain (COL14A1).